Gastric banding, metformin “equal” for slowing early T2DM progression

Clinical Endocrinology News highlighted a study by Thomas Buchanan, MD, professor of medicine, comparing gastric banding and metformin for improving insulin sensitivity in patients with early Type 2 diabetes in the following link:

https://www.mdedge.com/clinicalendocrinologynews/article/176467/diabetes/gastric-banding-metformin-equal-slowing-early-t2dm

Welcome to DORI

Welcome to the Diabetes & Obesity Research Institute (DORI) at the University of Southern California. Established in 2012, the DORI is a multi-disciplinary collaborative of investigators seeking to link basic, clinical, and public health research to advance the understanding of obesity and its relationship to type II diabetes. The Institute was designed to foster interactions across disciplinary boundaries; embrace methods and techniques from diverse fields of study; and develop effective approaches to risk assessment, prevention and treatment of the international co-epidemics of diabetes and obesity.
Upcoming Events
1. Seminar with Stephanie Correa, PhD University of California, Los Angeles
  
  September 8
2. Seminar with Peter Butler, MD University of California, Los Angeles
  
  October 13
3. Seminar with Steven Heymsfield, MD Louisiana State University
  
  November 17
4. Seminar with Alaina Vidmar, MD, Children’s Hospital Los Angeles
  
  January 12, 2021
View All Events

Contact Form

Gastric banding, metformin “equal” for slowing early T2DM progression

Welcome to DORI

Upcoming Events

Seminar with Stephanie Correa, PhD University of California, Los Angeles

Seminar with Peter Butler, MD University of California, Los Angeles

Seminar with Steven Heymsfield, MD Louisiana State University

Seminar with Alaina Vidmar, MD, Children’s Hospital Los Angeles